Litigation continues over use of contract pharmacies in 340B Drug Discount Program /
| Main Author: | Rogers, Hannah-Alise (Author) |
|---|---|
| Format: | Government Document Database |
| Language: | English |
| Published: |
[Washington, D.C.] :
Congressional Research Service,
2024-
|
| Edition: | [Library of Congress public edition]. |
| Series: | Legal sidebar ;
LSB11163. |
| Subjects: | |
| Online Access: | https://purl.fdlp.gov/GPO/gpo230393 |
Similar Items
Courts evaluate the role of contract phramacies in the 340B Drug Discount Program /
by: Rogers, Hannah-Alise
Published: (2022)
by: Rogers, Hannah-Alise
Published: (2022)
Drug discount program: federal oversight of compliance at 340B contract pharmacies needs improvement : report to congressional requesters.
Published: (2018)
Published: (2018)
Drug discount program: improvements needed in federal oversight of compliance at 340B contract pharmacies : testimony before the Subcommittee on Health, Committee, Energy and Commerce, House of Representatives /
by: Draper, Debra
Published: (2018)
by: Draper, Debra
Published: (2018)
Drug Discount Program : characteristics of hospitals participating and not participating In the 340B program.
Published: (2018)
Published: (2018)
340B Drug Discount Program : information about hospitals that received an eligibility exception as a result of COVID-19.
Published: (2023)
Published: (2023)
Supreme Court overturns HHS regulation reducing the Medicare outpatient drug reimbursement rate for 340B hospitals /
by: Liu, Edward C., et al.
Published: (2022)
by: Liu, Edward C., et al.
Published: (2022)
Perspectives on the 340B Drug Pricing Program : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fifteenth Congress, second session, on examining perspectives on the 340B drug discount program, March 15, 2018.
Published: (2020)
Published: (2020)
Drug discount program : status of agency efforts to improve 340B program oversight : testimony before the Committee on Health, Education, Labor & Pensions, U.S. Senate /
by: Draper, Debra
Published: (2018)
by: Draper, Debra
Published: (2018)
Examining oversight reports on the 340B Drug Pricing Program : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fifteenth Congress, second session, on examining oversight reports on the 340B Drug Pricing Program, May 15, 2018.
Published: (2020)
Published: (2020)
Reauthorization of the Prescription Drug User Fee Act : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, March 6, 2002.
Published: (2002)
Published: (2002)
Reauthorization of the Prescription Drug User Fee Act : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, March 6, 2002.
Published: (2002)
Published: (2002)
Medicare-endorsed prescription drug discount card : their impact on small business : hearing before the Committee on Small Business, House of Representatives, One Hundred Seventh Congress, first session, Washington, DC, October 25, 2001.
Published: (2002)
Published: (2002)
Internet pharmacy and drug importation : exploring risks and benefits : hearing before the Special Committee on Aging, United States Senate, One Hundred Ninth Congress, first session, Washington, DC, January 26, 2005.
Published: (2005)
Published: (2005)
Internet pharmacy and drug importation : exploring risks and benefits : hearing before the Special Committee on Aging, United States Senate, One Hundred Ninth Congress, first session, Washington, DC, January 26, 2005.
Published: (2005)
Published: (2005)
Lowering prescription drug prices : deconstructing the drug supply chain : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Sixteenth Congress, first session, May 9, 2019.
Published: (2021)
Published: (2021)
Examining HRSA's oversight of the 340B Drug Pricing Program : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, July 18, 2017.
Published: (2018)
Published: (2018)
Reauthorization of the Prescription Drug User Fee Act : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, April 17, 2007.
Published: (2008)
Published: (2008)
Reauthorization of the Prescription Drug User Fee Act : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, April 17, 2007.
Published: (2008)
Published: (2008)
Reauthorization of the Prescription User Fee Act and FDA reform : hearing before the Subcommittee on Health and Environment of the Committee on Commerce, House of Representatives, One Hundred Fifth Congress, first session, April 23, 1997.
Published: (1997)
Published: (1997)
Implementation of the Medicare Drug Price Negotiation Program : Centers for Medicare and Medicaid guidance and legal considerations /
by: Rogers, Hannah-Alise
Published: (2023)
by: Rogers, Hannah-Alise
Published: (2023)
Administrative Procedure Act challenges to CMS's implementation of the Medicare Drug Price Negotiation Program /
by: Rogers, Hannah-Alise
Published: (2024)
by: Rogers, Hannah-Alise
Published: (2024)
Prescription drugs : prices available through discount cards and from other sources.
by: Dummit, Laura A.
Published: (2001)
by: Dummit, Laura A.
Published: (2001)
Prescription drug prices : are we getting our money's worth? : a majority staff report of the Special Committee on Aging, United States Senate.
Published: (1989)
Published: (1989)
Guide to prescription drug costs /
Published: (1980)
Published: (1980)
Prices for brand-name drugs under selected federal programs.
by: Somers, Julie A. (Julie Ann), 1971-
Published: (2005)
by: Somers, Julie A. (Julie Ann), 1971-
Published: (2005)
Prices for brand-name drugs under selected federal programs.
by: Somers, Julie A. (Julie Ann), 1971-
Published: (2005)
by: Somers, Julie A. (Julie Ann), 1971-
Published: (2005)
The effects of escalating drug costs on the elderly : hearing before the Special Committee on Aging, United States Senate, One Hundred Second Congress, second session : morning session, Macon, GA, April 22, 1992; afternoon session, Atlanta, GA, April 22, 1992.
Published: (1992)
Published: (1992)
Requesting the President and directing the Secretary of Health and Human Services provide certain documents to the House of Representatives relating to estimates and analyses of the cost of the medicare prescription drug legislation : adverse report together with dissenting views (to accompany H.Res. 776) (including cost estimate of the Congressional Budget Office).
Published: (2004)
Published: (2004)
Why does the United States pay, by far, the highest prices in the world for prescription drugs? : hearing of the Committee on Health, Education, Labor and Pensions, United States Senate, One Hundred Eighteenth Congress, second session, on examining the cost of prescription drugs, February 8, 2024.
Published: (2024)
Published: (2024)
Prescription drug pricing : implications for retail pharmacies : statement of Sarah F. Jaggar, Director, Health Services Quality and Public Health, Health, Education, and Human Services Division, before the Subcommittee on Oversight and Investigations, Committee on Commerce, House of Representatives /
by: Jaggar, Sarah F.
Published: (1996)
by: Jaggar, Sarah F.
Published: (1996)
Why are some generic drugs skyrocketing in price? : hearing before the Subcommittee on Primary Health and Aging of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Thirteenth Congress, second session, on examining the pricing of generic drugs, November 20, 2014.
Published: (2017)
Published: (2017)
Comparative pricing of prescription drugs sold in the United States and Canada and the effects on U.S. customers [as printed] : hearing before the Subcommittee on Consumer Affairs, Foreign Commerce and Tourism of the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Seventh Congress, first session, September 5, 2001.
Published: (2003)
Published: (2003)
Physician dispensing of drugs : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One hundredth Congress, first session on H.R. 2093 ... April 22, 1987.
Published: (1987)
Published: (1987)
The Drug Competition Act of 2001 : report (to accompany S. 754).
Published: (2002)
Published: (2002)
Prescription drug and price advertising : hearings before the Subcommittee on Consumer Protection and Finance of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-fourth Congress, second session, on H.R. 882, H.R. 884, and all identical bills ...
Published: (1976)
Published: (1976)
Drug safety and pricing : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Sixth Congress, second session ... June 13, 2000.
Published: (2000)
Published: (2000)
Sudden price spikes in decades-old prescription drugs : inside the monopoly business model : hearing before the Special Committee on Aging, United States Senate, One Hundred Fourteenth Congress, second session, Washington, DC, March 17, 2016.
Published: (2022)
Published: (2022)
Examining prescription drug importation : a review of a proposal to allow third parties to reimport prescription drugs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, July 25, 2002.
Published: (2002)
Published: (2002)
The new handbook of prescription drugs: official names, prices, and sources for patient and doctor.
by: Burack, Richard
Published: (1970)
by: Burack, Richard
Published: (1970)
Affordable prescriptions now : examining legislation to lower costs for seniors : hearing before the Special Committee on Aging, United States Senate, One Hundred Seventeenth Congress, second session, Fayette, Georgia, July 21, 2022.
Published: (2022)
Published: (2022)